Novel pyrazolopyridines as cyclin dependent kinase inhibitors
    1.
    发明申请
    Novel pyrazolopyridines as cyclin dependent kinase inhibitors 有权
    新型吡唑并吡啶类作为细胞周期蛋白依赖性激酶抑制剂

    公开(公告)号:US20040097516A1

    公开(公告)日:2004-05-20

    申请号:US10664337

    申请日:2003-09-17

    CPC分类号: C07D471/04

    摘要: In its many embodiments, the present invention provides a novel class of pyrazolonull1,5-anullpyridine compounds as inhibitors of cyclin dependent kinases, methods of preparing such compounds, pharmaceutical compositions containing one or more such compounds, methods of preparing pharmaceutical formulations comprising one or more such compounds, and methods of treatment, prevention, inhibition, or amelioration of one or more diseases associated with the CDKs using such compounds or pharmaceutical compositions.

    摘要翻译: 在其许多实施方案中,本发明提供了一类新颖的吡唑并[1,5-a]吡啶化合物作为细胞周期蛋白依赖性激酶的抑制剂,制备此类化合物的方法,含有一种或多种此类化合物的药物组合物,制备药物制剂的方法 包括一种或多种这样的化合物,以及使用这些化合物或药物组合物治疗,预防,抑制或改善与CDK相关的一种或多种疾病的方法。

    Novel imidazopyridines as cyclin dependent kinase inhibitors
    3.
    发明申请
    Novel imidazopyridines as cyclin dependent kinase inhibitors 有权
    新型咪唑并吡啶类作为细胞周期蛋白依赖性激酶抑制剂

    公开(公告)号:US20040097517A1

    公开(公告)日:2004-05-20

    申请号:US10664338

    申请日:2003-09-17

    CPC分类号: C07D471/04

    摘要: In its many embodiments, the present invention provides a novel class of imidazonull1,2-anullpyridine compounds as inhibitors of cyclin dependent kinases, methods of preparing such compounds, pharmaceutical compositions containing one or more such compounds, methods of preparing pharmaceutical formulations comprising one or more such compounds, and methods of treatment, prevention, inhibition, or amelioration of one or more diseases associated with the CDKs using such compounds or pharmaceutical compositions.

    摘要翻译: 在其许多实施方案中,本发明提供了一类新颖的咪唑并[1,2-a]吡啶化合物作为细胞周期蛋白依赖性激酶的抑制剂,制备此类化合物的方法,含有一种或多种此类化合物的药物组合物,制备药物制剂的方法 包括一种或多种这样的化合物,以及使用这些化合物或药物组合物治疗,预防,抑制或改善与CDK相关的一种或多种疾病的方法。